查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855817

无细胞DNA（cfDNA）血液采集管全球市场报告（2025年）

Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，无细胞DNA（cfDNA）血液采集管的市场规模迅速扩张，从2024年的11.7亿美元成长到2025年的13.3亿美元，复合年增长率达13.8%。这一增长主要受以下因素驱动：生活方式相关疾病的日益普遍、早期基因筛检计画的推广、基于血液的生物标记研究的广泛应用、全球诊断实验室数量的增长以及人们对母婴健康监测意识的提高。

预计未来几年，无细胞DNA（cfDNA）血液采集管市场将快速成长，到2029年市场规模将达到22亿美元，复合年增长率（CAGR）为13.4%。预测期内的成长预计将受到以下因素的推动：患者对微创手术的偏好日益增强、cfDNA在移植监测中的广泛应用、政府加大倡议推广分子诊断、对高效样本运输和储存的需求不断增长，以及分子诊断检测的保险覆盖范围扩大。预测期内的主要偏好包括：微流体控血液采集管技术的进步、永续和环保型血液采集管材料的创新、人工智慧在数据驱动诊断中的应用、产前和肿瘤检测流程的改进，以及伴随诊断在标靶治疗中的应用。

无细胞DNA (cfDNA) 采集管是专门用于采集、稳定和运输血液样本以进行cfDNA分析的装置。它们含有防腐剂，可保护核酸免受降解，并最大限度地减少白血球基因组DNA的释放。这些采集管有助于在液态切片、产前检测和癌症诊断等下游应用中获得准确可靠的结果。

无细胞DNA（cfDNA）血液采集管市场主要由5毫升和10毫升的采集管组成。 5毫升cfDNA血液采集管是一种小容量选择，常用于个人或常规样本采集。样本类型包括血浆、血清和全血。应用领域涵盖体外诊断和科学研究。主要终端使用者包括诊断实验室、医院、临床中心、基因诊断实验室、癌症研究中心、研发机构和传统诊断机构。

美国关税的快速上涨以及随之而来的2025年春季贸易摩擦，正对医疗设备产业产生重大影响，尤其是进口诊断影像设备零件、手术用不銹钢和塑胶耗材。医院和诊所都在抵制价格上涨，这挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供无细胞DNA（cfDNA）采血管市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和机会，以及您在无细胞DNA（cfDNA）采血管行业取得成功所需的数据。本无细胞DNA（cfDNA）采血管市场研究报告对产业现状和未来发展趋势进行了详细分析，为您提供所需的一切资讯。

预计未来几年，呼吸系统疾病的日益普遍将推动无细胞DNA（cfDNA）采集管市场的成长。呼吸系统疾病是指影响肺部及呼吸系统其他部位的疾病，这些疾病会导致呼吸困难，影响血液供氧和二氧化碳排出。呼吸系统疾病盛行率的上升主要是由于空气污染，空气污染会刺激呼吸道，降低肺功能，并增加气喘、支气管炎、慢性阻塞性肺病（COPD）和其他疾病的风险。无细胞DNA（cfDNA）采集管在呼吸系统疾病管理中发挥关键作用，它可以透过简单的血液检测来检测基因突变、追踪疾病进展并评估治疗效果，从而减少侵入性肺部切片检查的需求。例如，2024 年 12 月，美国政府机构疾病管制与预防中心 (CDC) 报告称，据估计，2024 年 10 月 1 日至 11 月 30 日期间，呼吸道融合细胞病毒(RSV) 导致 17,000 至 34,000 人住院。呼吸道疾病发生率的上升正在推动 cfDNA 采集管的需求。

癌症发生率的上升预计将推动无细胞DNA（cfDNA）采集管市场的未来成长。 cfDNA采集管越来越多地用于癌症治疗中的液态生物检体液态切片，透过简单的血液检测即可检测肿瘤特异性基因突变、监测疾病进展、评估治疗反应并识别抗药性突变。这种方法减少了侵入性组织切片检查的需求。例如，美国国家癌症研究所（美国政府机构）在2024年5月预测，美国癌症倖存者人数将从2022年的1810万人增加到2040年的26​​00万人。因此，癌症发生率的上升正在推动cfDNA采集管的需求。

在cfDNA血液采集管市场运作的主要企业正致力于实现cfDNA提取的自动化，以提高工作流程效率。 cfDNA提取自动化是指利用先进的机器人系统和标准化流程，以最少的人工干预从血液样本中分离游离DNA，从而提高效率、准确性和一致性，同时缩短週转时间并减少人为错误。例如，英国分子诊断公司Yourgene Health plc于2023年9月推出了MagBench自动化DNA萃取仪和试剂盒。该解决方案提供了一种快速、便捷且经济高效的桌上型机器人方案，专为非侵入性产前检测（NIPT）工作流程中的cfDNA提取而优化。此次发布旨在增强NIPT工作流程的自动化程度，提高cfDNA提取的通量、可重复性和可靠性，同时减少人工时间和营运成本。

无细胞DNA（cfDNA）血液采集管市场包括血浆分离管、低温储存系统和血浆预处理离心系统的销售。该市场的价值为“出厂价”，即製造商或生产商向其他营业单位（包括下游製造商、经销商、分销商和零售商）或直接向最终客户销售的商品价值。该市场商品价值还包括製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球无细胞DNA（cfDNA）血液采集管：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球无细胞DNA（cfDNA）采血管市场：成长率分析
  • 全球无细胞DNA（cfDNA）血液采集管市场表现：规模和成长，2019-2024年
  • 全球无细胞DNA（cfDNA）血液采集管市场预测：规模和成长，2024-2029年，2034年预测
  • 全球无细胞DNA（cfDNA）血液采集管：潜在市场规模（TAM）

第六章 市场细分

  • 全球无细胞DNA（cfDNA）采血管市场：按类型、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 5ml
  • 10ml
  • 全球无细胞DNA（cfDNA）血液采集管市场依样本类型、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 电浆
  • 血清
  • 全血
  • 全球无细胞DNA（cfDNA）采血管市场：依应用、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 体外诊断
  • 科学研究
  • 全球无细胞DNA（cfDNA）血液采集管市场：依最终用户、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 诊断实验室
  • 医院或临床中心
  • 基因诊断实验室
  • 癌症研究中心
  • 研究与发展研究所
  • 传统诊断中心
  • 全球无细胞DNA（cfDNA）采血管市场：依5毫升、类型、表现细分及预测（2019-2024年、2024-2029年预测、2034年预测）。
  • 免洗管
  • 真空采血管
  • 凝胶分离管
  • 全球无细胞DNA（cfDNA）采血管市场：10毫升细分市场：按类型划分，实际结果和预测，2019-2024年、2024-2029年预测、2034年预测
  • 双抽管
  • 大容量采血管
  • 抗凝血剂处理过的试管

第七章 区域和国家分析

  • 全球无细胞DNA（cfDNA）血液采集管市场：按地区、绩效和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球无细胞DNA（cfDNA）血液采集管市场：按国家/地区、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 无细胞DNA（cfDNA）血液采集管市场：竞争格局
  • 无细胞DNA（cfDNA）血液采集管市场：公司概况
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • SARSTEDT AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Guangzhou Improve Medical Technology
  • Streck Inc.
  • DiaCarta Inc.
  • Zymo Research Corporation
  • Biomatrica Inc.
  • PreAnalytiX GmbH
  • Beijing Cowin Bioscience Co.Ltd.
  • Norgen Biotek Corporation
  • Nonacus Limited
  • Guangdong Ardent Biomed Co. Ltd
  • MagBio Genomics Inc.
  • VanGenes
  • BEAVER
  • Hebei Xinle Science & Technology Co. Ltd.
  • Nasmed Diagnostics Pvt. Ltd.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 无细胞DNA（cfDNA）血液采集管市场展望（2029）：提供新机会的国家
  • 无细胞DNA（cfDNA）血液采集管市场2029：新兴细分市场机会
  • 无细胞DNA（cfDNA）血液采集管市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38466

A cell-free DNA (cfDNA) blood collection tube is a specialized device designed to collect, stabilize, and transport blood samples for cfDNA analysis. It contains preservatives that protect nucleic acids from degradation and minimize the release of genomic DNA from white blood cells. These tubes support accurate and reliable results in downstream applications such as liquid biopsy, prenatal testing, and cancer diagnostics.

The primary types in the cell-free DNA (cfDNA) blood collection tube market are 5 mL and 10 mL. The 5 mL cfDNA blood collection tube is a smaller-volume option commonly used for individual or routine sample collection. Sample types include plasma, serum, and whole blood. Applications cover in vitro diagnostics and scientific research. Key end-users include diagnostic laboratories, hospitals and clinical centers, genetic diagnostic labs, cancer research centers, research and development institutions, and conventional diagnostic facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cell-free DNA (cfDNA) blood collection tube market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) blood collection tube market statistics, including cell-free DNA (cfDNA) blood collection tube industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) blood collection tube market share, detailed cell-free DNA (cfDNA) blood collection tube market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) blood collection tube industry. The cell-free DNA (cfDNA) blood collection tube market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free DNA (cfDNA) blood collection tube market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.33 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. Growth in the historic period was driven by the increasing prevalence of lifestyle-related disorders, greater emphasis on early genetic screening programs, wider acceptance of blood-based biomarker research, growth in the number of diagnostic laboratories worldwide, and rising awareness of maternal and fetal health monitoring.

The cell-free DNA (cfDNA) blood collection tube market size is expected to see rapid growth in the next few years. It will grow to $2.20 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. Growth in the forecast period is expected to be supported by increasing patient preference for minimally invasive procedures, wider use of cfDNA in transplant monitoring, stronger government initiatives promoting molecular diagnostics, greater demand for efficient sample transport and storage, and expanded insurance coverage for molecular diagnostic tests. Key trends anticipated for the forecast period include advancements in microfluidics-enabled blood collection tubes, innovation in sustainable and eco-friendly tube materials, integration of artificial intelligence for data-driven diagnostics, improvements in prenatal and oncology testing workflows, and the use of companion diagnostics to support targeted therapies.

The rising prevalence of respiratory disorders is expected to drive the growth of the cell-free DNA (cfDNA) blood collection tube market in the coming years. Respiratory disorders are conditions that impact the lungs and other parts of the respiratory system, making it difficult to breathe properly and affecting the delivery of oxygen to the blood or removal of carbon dioxide from the body. The growing prevalence of respiratory disorders is largely attributed to air pollution, which irritates the airways, decreases lung function, and heightens the risk of conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Cell-free DNA (cfDNA) blood collection tubes play a crucial role in managing respiratory disorders by detecting genetic mutations, tracking disease progression, and assessing treatment effectiveness with a simple blood test, reducing the need for invasive lung biopsies. For instance, in December 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that between October 1 and November 30, 2024, respiratory syncytial virus (RSV) led to an estimated 17,000 to 34,000 hospitalizations. Thus, the increasing occurrence of respiratory disorders is fueling the demand for cfDNA blood collection tubes.

The rising incidence of cancer is expected to drive growth in the cell-free DNA (cfDNA) blood collection tube market in the future. The growing number of cancer cases is linked to lifestyle factors such as poor diet, smoking, and lack of physical activity. cfDNA blood collection tubes are increasingly used in cancer care for liquid biopsies, which allow for the detection of tumor-specific genetic mutations, monitoring of disease progression, evaluation of treatment responses, and identification of resistance mutations through a simple blood test. This method reduces the need for invasive tissue biopsies. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, projected that the number of cancer survivors in the U.S. would rise to 26 million by 2040, up from 18.1 million in 2022. Therefore, the growing incidence of cancer is driving the demand for cfDNA blood collection tubes.

Key companies operating in the cfDNA blood collection tube market are focusing on automating cfDNA extraction to improve workflow efficiency. Automation of cfDNA extraction involves the use of advanced robotic systems and standardized procedures to isolate cell-free DNA from blood samples with minimal manual intervention, enhancing efficiency, accuracy, and consistency while reducing turnaround times and human error. For example, in September 2023, Yourgene Health plc, a molecular diagnostics company based in the UK, introduced the MagBench Automated DNA Extraction Instrument and Kit. This solution provides a fast, simple, and cost-effective bench-top robotic option optimized for cfDNA extraction in non-invasive prenatal testing (NIPT) workflows. The launch aims to enhance automation in NIPT workflows, delivering higher throughput, reproducibility, and reliability in cfDNA extraction while reducing hands-on time and operational expenses.

Major players in the cell-free DNA (cfDNA) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell-free DNA (cfDNA) blood collection tube report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell-free DNA (cfDNA) blood collection tube market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell-free DNA (cfDNA) blood collection tube market consists of sales of plasma separation tubes, cryogenic storage systems, and plasma prep centrifugation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell-free dna (cfdna) blood collection tube market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) blood collection tube ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) blood collection tube market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: 5ml; 10ml
  • 2) By Sample Type: Plasma; Serum; Whole Blood
  • 3) By Application: In Vitro Diagnostics; Scientific Research
  • 4) By End-User: Diagnostic Laboratories; Hospitals Or Clinical Centers; Genetic Diagnostic Labs; Cancer Research Centers; Research And Development Institutions; Conventional Diagnostic Centers
  • Subsegments:
  • 1) By 5 mL: Single Use Tube; Vacuum Blood Collection Tube; Gel Separator Tube
  • 2) By 10 mL: Double Draw Tube; High Volume Collection Tube; Anticoagulant Treated Tube
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Becton Dickinson (BD); Qiagen N.V.; SARSTEDT AG & Co. KG; Guangzhou Improve Medical Technology; Streck Inc.; DiaCarta Inc.; Zymo Research Corporation; Biomatrica Inc.; PreAnalytiX GmbH; Beijing Cowin Bioscience Co.Ltd.; Norgen Biotek Corporation; Nonacus Limited; Guangdong Ardent Biomed Co. Ltd; MagBio Genomics Inc.; VanGenes; BEAVER; Hebei Xinle Science & Technology Co. Ltd.; Nasmed Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Blood Collection Tube Market Characteristics

3. Cell-Free DNA (cfDNA) Blood Collection Tube Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Blood Collection Tube Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Growth Rate Analysis
  • 5.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell-Free DNA (cfDNA) Blood Collection Tube Total Addressable Market (TAM)

6. Cell-Free DNA (cfDNA) Blood Collection Tube Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 5ml
  • 10ml
  • 6.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma
  • Serum
  • Whole Blood
  • 6.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vitro Diagnostics
  • Scientific Research
  • 6.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Hospitals Or Clinical Centers
  • Genetic Diagnostic Labs
  • Cancer Research Centers
  • Research And Development Institutions
  • Conventional Diagnostic Centers
  • 6.5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 5Ml, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Use Tube
  • Vacuum Blood Collection Tube
  • Gel Separator Tube
  • 6.6. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 10Ml, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Double Draw Tube
  • High Volume Collection Tube
  • Anticoagulant Treated Tube

7. Cell-Free DNA (cfDNA) Blood Collection Tube Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 9.1. China Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 10.1. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 16.1. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 18.1. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 23.1. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 24.1. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 26.1. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Blood Collection Tube Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SARSTEDT AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Free DNA (cfDNA) Blood Collection Tube Market Other Major And Innovative Companies

  • 31.1. Guangzhou Improve Medical Technology
  • 31.2. Streck Inc.
  • 31.3. DiaCarta Inc.
  • 31.4. Zymo Research Corporation
  • 31.5. Biomatrica Inc.
  • 31.6. PreAnalytiX GmbH
  • 31.7. Beijing Cowin Bioscience Co.Ltd.
  • 31.8. Norgen Biotek Corporation
  • 31.9. Nonacus Limited
  • 31.10. Guangdong Ardent Biomed Co. Ltd
  • 31.11. MagBio Genomics Inc.
  • 31.12. VanGenes
  • 31.13. BEAVER
  • 31.14. Hebei Xinle Science & Technology Co. Ltd.
  • 31.15. Nasmed Diagnostics Pvt. Ltd.

32. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Blood Collection Tube Market

34. Recent Developments In The Cell-Free DNA (cfDNA) Blood Collection Tube Market

35. Cell-Free DNA (cfDNA) Blood Collection Tube Market High Potential Countries, Segments and Strategies

  • 35.1 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer